Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Prosch

Showing results (51-60 of 51) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 51 results.
ESMO Open|June 7, 2023
Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trialN Girard, S Ponce Aix, S Cedres, et al.
Pageof 6

Showing results (51-60 of 51) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 51 results.
ESMO Open|June 7, 2023
Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trialN Girard, S Ponce Aix, S Cedres, et al.
Pageof 6